Morbidity not increased in rheumatoid arthritis patient with profound lymphopenia following CD4 monoclonal antibody therapy: comment on the article by Isaacs et al.
Yamini
Y
Menon
Ranju
R
Singh
Raquel
R
Cuchacovich
Luis R
LR
Espinoza
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000961:Antilymphocyte Serum / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D015704:CD4 Antigens / Q000276:immunology*; D005260:Female; D006801:Humans; D008231:Lymphopenia / Q000209:etiology*
D000911:Antibodies, Monoclonal; D000961:Antilymphocyte Serum; D015704:CD4 Antigens